Focus: Schrodinger is a computational drug discovery platform company headquartered in San Diego with 501–1,000 employees, leveraging physics-based software to accelerate early-stage drug development. The company operates as a B2B/B2C technology enabler rather than a traditional pipeline-driven biotech.
Profile data last refreshed 14h ago · AI intelligence enriched 3w ago
No open roles listed right now. Follow Schrodinger to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
No open positions listed yet. Check their careers page directly.
Recent peer-reviewed publications with author affiliations at this company
Help build intelligence for Schrodinger
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Schrodinger's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
In Situ Lipid Interactions of an Anticancer Metal Complex.
Luminescent Copper(I) Complexes with Dual Bridging Ligands and Excitation-Dependent Emission.
An Accurate Charge-Aware Machine-Learning Interatomic Potential for the Reduction of Li-Ion Battery Electrolytes in Solution.
Mechanistic basis for improved activity of Engineered AsCas12a.
Evaluating Multiconfigurational Trials for Accurate Phaseless Auxiliary-Field Quantum Monte Carlo on 3d Transition Metal Complexes.
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo